Latest / Pharmacy Podcast Network / Is Your Marketing Compliant | Marketing Vitals

Transcript

Is Your Marketing Compliant | Marketing Vitals · Pharmacy Podcast Network

0:05
Speaker 1: You are listening to the global network of podcasters dedicated
0:09
Speaker 1: to the pharmacy profession. Welcome to the Pharmacy podcast Network.
0:25
Speaker 2: As your business is marketing flatlined, find your pulse again
0:30
Speaker 2: with Marketing Vitals, bringing you innovative, in turn key healthcare
0:34
Speaker 2: marketing solutions from industry experts who have developed a knack
0:38
Speaker 2: for solving problems. A co hosted publication from GRX Marketing
0:42
Speaker 2: and Finch Marketing, sister companies that are passionate and knowledgeable
0:46
Speaker 2: about healthcare marketing.
0:47
Speaker 3: Hey, everyone, welcome to another episode of Marketing Vitals podcast.
0:53
Speaker 3: I'm Nicole McClure, president of GRX and Finch Marketing, and
0:57
Speaker 3: so excited to be here today and talk to our guest.
1:00
Speaker 3: I love to introduce Darshaun ku Connie. He is a farmacist,
1:05
Speaker 3: a regulatory and compliance attorney, a fellow podcaster. I think
1:11
Speaker 3: I got everything, Darshawn, Welcome to the show. Did I
1:14
Speaker 3: miss something?
1:16
Speaker 4: A few things, but I'm sure they'll be okay. I
1:20
Speaker 4: write various books. If you see the books behind me,
1:23
Speaker 4: I've written anywhere from one through six chapters, and every
1:25
Speaker 4: single one of them. I teach at directs law, I
1:28
Speaker 4: teach pharmaceutical marketing.
1:31
Speaker 5: I also.
1:33
Speaker 4: I speak all over the world on marketing and compliance
1:36
Speaker 4: and pharmacy related issues, if you will. I was just
1:41
Speaker 4: attend of conference last week in New York where I
1:45
Speaker 4: was presenting on it.
1:47
Speaker 5: I keynoted various.
1:48
Speaker 4: Events, and I'm sure there's more, but I forgot. I'm
1:54
Speaker 4: on I'm a board chair for multiple organizations.
1:57
Speaker 5: Yeah.
1:58
Speaker 3: Perfect, well, so all of that experience definitely lends you
2:04
Speaker 3: to be a great guest on our show today. So
2:07
Speaker 3: I wanted to talk to you about just marketing for
2:10
Speaker 3: pharmacies and compliance.
2:13
Speaker 5: I feel like.
2:14
Speaker 3: Over the last couple of years, you know, from our
2:16
Speaker 3: perspective of working with a lot of independence, it's become
2:20
Speaker 3: much more complicated and challenging for them. Can you kind
2:26
Speaker 3: of talk about what you've seen on your side as
2:29
Speaker 3: far as how it's become more challenging.
2:33
Speaker 5: Oh, where do we start? Cool this?
2:36
Speaker 4: This is this is sort of the multi billion dollar
2:39
Speaker 4: question right now. Pharmacies don't quite appreciate how big an
2:43
Speaker 4: issue it is. We can talk about a variety of
2:46
Speaker 4: different things at different levels, but let's let's start with
2:51
Speaker 4: the first element, which is.
2:55
Speaker 5: Marketing.
2:56
Speaker 4: That's uh connected to say, like equipment manufacturers were selling
3:02
Speaker 4: the equipment to pharmacies. A lot of those guys got
3:06
Speaker 4: in trouble because they were falsely billing Medicare and Medicaid,
3:10
Speaker 4: and essentially their marketing, the way they organize their marketing
3:13
Speaker 4: groups was set up in a way that these patients
3:16
Speaker 4: were receiving like orthopedic stuff or devices that they really
3:24
Speaker 4: didn't need. It was more of a churning game to
3:27
Speaker 4: see if they can build Medicare and Medicaid for as
3:30
Speaker 4: much as they could. And it's one thing to do
3:32
Speaker 4: that if you're trying to help patients. It's another thing
3:35
Speaker 4: if it's basically just a route to build Medicare and Medicaid.
3:39
Speaker 4: So if it's unnecessary, you end up paying a bunch
3:44
Speaker 4: of money for it. So if your pharmacy was involved
3:46
Speaker 4: in that process, you can get people into trouble. The
3:49
Speaker 4: second element that I've seen is sort of pharmacists who
3:52
Speaker 4: involved in clinical research and they were marketing their services
3:58
Speaker 4: in a way that was less about the research and
4:01
Speaker 4: more about the more more about the sales process and
4:06
Speaker 4: dispensing products, and that came into different forums. We'll talk
4:10
Speaker 4: about one form now and we'll talk about another form later,
4:13
Speaker 4: but that first version landed up becoming something that's targeted.
4:18
Speaker 5: People have gone to jail over it.
4:20
Speaker 4: You had pharmacy technicians and pharmacists go to jail over that,
4:23
Speaker 4: So that's number two. Then you had number three, which
4:26
Speaker 4: was compounding pharmacies, and that's a whole other beast. And
4:32
Speaker 4: the reason you get mixed in this area is because
4:38
Speaker 4: compounding pharmacies are often doing a cash based system, So
4:44
Speaker 4: the traditional Medicare Medicaid got defrauded doesn't work in that scenario.
4:50
Speaker 4: You may have some state laws that kick in, but
4:52
Speaker 4: not at the federal level. However, patients are challenged and
5:00
Speaker 4: because there are other federal rules that kick in, for
5:04
Speaker 4: example on transparency on disclosure, so the FTC has has
5:09
Speaker 4: something to say about it. The FDA could take the
5:12
Speaker 4: position they have that it is false and misleading. The
5:16
Speaker 4: state boards have pulled it, have called it out multiple
5:18
Speaker 4: different times as the advertising tends to be non compliant.
5:25
Speaker 4: You you also have uh uh, these pharmacies who would
5:30
Speaker 4: sort of say you can have any compounded medication you
5:34
Speaker 4: want as long as there's this one.
5:36
Speaker 5: So we used to see that a.
5:38
Speaker 4: Long time ago, in like the dea world where pharmacists
5:42
Speaker 4: would compound specific medications and have pre printed prescription pads
5:47
Speaker 4: and the doctor would just check off the one they wanted,
5:50
Speaker 4: and that was very common, and that was seen to
5:52
Speaker 4: be problematic because you're not saying that the doctor can
5:55
Speaker 4: customize anything. You're basically manufacturing and the doctors choosing that medicaid.
6:00
Speaker 5: Well, we're doing the.
6:01
Speaker 4: Exact same thing in this uh in the g l
6:04
Speaker 4: P one world, and that's becoming problematic because you're talking
6:09
Speaker 4: about drugs that are either unapproved, you're talking about drugs
6:13
Speaker 4: that are approved. But this is not on a shortage
6:18
Speaker 4: list anymore. So it's not it's not something you're going
6:20
Speaker 4: through A five or three B four or it's a
6:22
Speaker 4: five O three A and you're adding something to quote
6:24
Speaker 4: unquote customize it.
6:26
Speaker 5: But it's a pre printed sheet.
6:27
Speaker 4: You're going to add like, I don't know, vitamin B
6:29
Speaker 4: twelve in it, and it's practically not going to have
6:32
Speaker 4: any any commercial effect, any actual appreciable clinical effect, and
6:37
Speaker 4: that's come back to bite companies as well. And then
6:41
Speaker 4: you have this other variety of pharmacists who are basically
6:47
Speaker 4: going out there and making medications, so tablets and they're
6:54
Speaker 4: pre they're making tablets of semi gluetide or tire zipetide.
6:59
Speaker 4: I don't think I've seen this as a tide version.
7:01
Speaker 4: I can't remember, to be honest. When they don't have
7:05
Speaker 4: any of the appropriate UH filings for an either of
7:08
Speaker 4: five or five B one or B two with the
7:12
Speaker 4: f DA. So again you're asking for all kinds of
7:15
Speaker 4: regulatory problems and UH consumer protection problems from lawyers and
7:21
Speaker 4: from the regulatory agencies and then the state bar state
7:24
Speaker 4: boards as well. So and these are just some of
7:26
Speaker 4: the examples of right right, Yeah.
7:31
Speaker 3: Do you see then, because I know with g LP ones,
7:35
Speaker 3: you know, at first there was yeah, some litigation or
7:39
Speaker 3: just threats against pharmacies that were compounding. And now that
7:47
Speaker 3: it's you know, not as popular as far as it
7:51
Speaker 3: is more commercially available, but pharmacies are still doing it.
7:55
Speaker 3: Do you still see that action that the FDA other
7:58
Speaker 3: government groups are coming after pharmacies for those that are
8:02
Speaker 3: continuing to compound it?
8:03
Speaker 5: Then yes, So we're seeing that right now.
8:06
Speaker 4: We're seeing that with large companies as well, because the
8:10
Speaker 4: government is looking for a scapegoat, someone that they are
8:13
Speaker 4: going to go after and make an example out of.
8:17
Speaker 4: I can't remember whether it was Row or Hymns and
8:20
Speaker 4: my memory, I'm sure we can double check that. I
8:23
Speaker 4: think it was Hymns as well, where they are being
8:26
Speaker 4: referred to the Department of Justice for the claims that
8:29
Speaker 4: they were making. But again we have a double check
8:33
Speaker 4: which company was. And that's an example of the government
8:39
Speaker 4: taking it very, very seriously. But as you pointed out,
8:44
Speaker 4: this isn't the end. I think pharmacies have been fighting
8:47
Speaker 4: back in Pharmacies are saying why can't we make it?
8:49
Speaker 4: And the answer is very simple, because you didn't go
8:51
Speaker 4: through the approval process. If you want to go through
8:54
Speaker 4: the approval process, go ahead.
8:55
Speaker 5: And sell it.
8:56
Speaker 4: But that's a different beast. I think that the next
8:59
Speaker 4: step is going to be peptides, and I think that's
9:01
Speaker 4: going to raise all kinds of new havoc that we.
9:04
Speaker 5: Simply don't know how to deal with.
9:06
Speaker 4: I was again at that conference last week, and people
9:09
Speaker 4: are still trying to figure out what to do with
9:10
Speaker 4: peptides because they're known to be unapproved products.
9:14
Speaker 5: So how do you.
9:14
Speaker 4: Make a compounded version of something who's API itself was
9:20
Speaker 4: never approved And that's going to be problematic as going forward.
9:25
Speaker 5: So we had some ideas.
9:27
Speaker 4: And we'll see if anything lends out of them, but
9:29
Speaker 4: we'll see.
9:30
Speaker 3: Yeah, and the independent pharmacies that we work with, I mean,
9:33
Speaker 3: especially on GLP one's compounding marketing. I mean, the biggest
9:37
Speaker 3: issue we see is they want to try to make
9:40
Speaker 3: false claims. And I think there's this bit of conception
9:45
Speaker 3: that well, we're a small pharmacy, like you know, FDA
9:49
Speaker 3: is not going to find out or we're not going
9:52
Speaker 3: to get in trouble that sort of thing. But I
9:55
Speaker 3: think it's just a slippery slope that they're trying to
9:57
Speaker 3: go down, you know, as this just continues to be
10:01
Speaker 3: an issue.
10:03
Speaker 5: So few different questions concerns with this.
10:07
Speaker 4: So number one in the end, what you're really going
10:11
Speaker 4: is we have a highway with a bunch of cars
10:15
Speaker 4: speeding on it. How many people can the cops stop?
10:18
Speaker 5: I don't know, if I really want.
10:19
Speaker 3: To find anology.
10:20
Speaker 4: Yeah, and yes, theoretically the cop could only stop one
10:26
Speaker 4: company at a time. Except the FDA is not as
10:30
Speaker 4: understaffed as you think. Uh, the FDA, if I last
10:34
Speaker 4: time I checked you by going back several years, at
10:35
Speaker 4: this point, the fd had like seventy seven thousand employees.
10:39
Speaker 4: Out of that, if I remember correctly, a thousand are
10:41
Speaker 4: in advertising and promotion just CDR.
10:45
Speaker 5: So that's OPDP.
10:46
Speaker 4: That's not counting the Office of Autopprooved Drugs, that's not
10:48
Speaker 4: counting Apple B, that's not counting CDRH. But it's it's
10:53
Speaker 4: not an insignificant number. You then add on the you
10:59
Speaker 4: add on the FTC, You add on the state Attorney generals,
11:03
Speaker 4: you add on a.
11:05
Speaker 5: State board of pharmacy.
11:07
Speaker 4: You add on lawyers who are now going you know what,
11:11
Speaker 4: maybe a small pharmacy someone I could ignore, but I
11:14
Speaker 4: can go after hymns. I can go after ROW. You
11:17
Speaker 4: can see more of those guys. And once you do
11:20
Speaker 4: the hymns in the rows and you succeed and you've
11:21
Speaker 4: got these multi billion dollar companies, you're going to go
11:24
Speaker 4: after small pharmacies as well.
11:26
Speaker 3: Yeah, are you so impressed to them?
11:28
Speaker 4: So do you really want to be in a position
11:30
Speaker 4: where you're just a target? You know you're a target
11:34
Speaker 4: and you're going to be targeted, and you're just waiting
11:37
Speaker 4: for that right moment Because I would also argue that
11:40
Speaker 4: I don't know if your insurance will cover you. So
11:43
Speaker 4: you've spent a lot of time as a pharmacy owner,
11:46
Speaker 4: building your business, protecting your children, growing your pharmacy and
11:52
Speaker 4: you're risking it now for what for an extra I
11:55
Speaker 4: don't know. Ten thousand dollars this year, one hundred thousand
11:59
Speaker 4: dollars this year, I don't know, But the point being,
12:01
Speaker 4: I don't know if it's worth it. I don't from
12:03
Speaker 4: me personally, wasn't I wouldn't risk my pharmacy.
12:05
Speaker 5: License for that, right?
12:07
Speaker 6: Right?
12:09
Speaker 3: What are you seeing as far as like AI and
12:13
Speaker 3: compliance with pharmacy marketing? So you know, we of course
12:20
Speaker 3: have a lot of clients that are like, we'll send
12:22
Speaker 3: us something and clearly you can tell it's been run
12:25
Speaker 3: through AI. And I think AI has its purpose, but
12:29
Speaker 3: I've found in healthcare it's inaccurate a lot and so
12:34
Speaker 3: but it's just like we're taking this gold standard around
12:38
Speaker 3: it that well, you know, AI told me, so it
12:40
Speaker 3: has to be one hundred percent true from a compliance standpoint,
12:44
Speaker 3: I guess kind of what are you've seen on that side?
12:48
Speaker 5: So a couple of different things. So I think the
12:50
Speaker 5: first thing is.
12:54
Speaker 4: There's actually a manufacture very recently who used an AI
12:58
Speaker 4: as the compliance tool chest and the FDA came in
13:02
Speaker 4: and they were like, what are you guys doing and
13:05
Speaker 4: why don't you have this documentation build up. And the
13:07
Speaker 4: guy literally said, because AI told me to, and why
13:10
Speaker 4: don't you fill out this one? Because AI told me to?
13:13
Speaker 4: And the FDA went, no, that's not how any of
13:16
Speaker 4: this works. You don't get to blame AI for this.
13:19
Speaker 4: You need to have systems in place. Those systems need
13:22
Speaker 4: to work. AI can help you, but it does not
13:26
Speaker 4: eliminate the need for the systems. On top of that,
13:29
Speaker 4: the DOJ, the Department of Justice, has already come out
13:32
Speaker 4: and said that in the end, fraud using AI is
13:35
Speaker 4: still fraud. Right, So I and then there's the actual
13:42
Speaker 4: and you say this as a marketer, I can only
13:45
Speaker 4: imagine what you see that's being generated by AI, because
13:51
Speaker 4: I can tell you the vast majority of stuff that
13:53
Speaker 4: I see. Number one, it's incredibly clocky as AI.
13:57
Speaker 5: Right, and you're just.
13:58
Speaker 4: Going no, I mean maybe about five years ago this
14:01
Speaker 4: was glossy and cool, but now it just looks like
14:05
Speaker 4: something someone's just going to scroll over. Because I know
14:08
Speaker 4: if I see something from AI, I don't want to
14:10
Speaker 4: read it anymore. Right, if I can, even if I
14:14
Speaker 4: even believe a thing, and I could be wrong that
14:17
Speaker 4: it was written by AI, I don't want to read
14:20
Speaker 4: it anymore. I sometimes have to use AI as like
14:23
Speaker 4: an initial generation point and then clean it up and
14:27
Speaker 4: then honestly even make some mistakes in there, just like
14:30
Speaker 4: I may know that it's a mistake. And when I
14:32
Speaker 4: say mistake in terms of like formatting, not in terms
14:35
Speaker 4: of content, but the idea being that people want to
14:40
Speaker 4: read something human right. And that's just purely from a
14:44
Speaker 4: marketing standpoint. From a compliance standpoint, you're still responsible for
14:49
Speaker 4: what it says, the binds and penalties.
14:52
Speaker 5: I have a friend and you probably know him.
14:56
Speaker 4: He's working at a farmer company, and he informed me
15:02
Speaker 4: that he's surprised how long approval takes in a farmer
15:08
Speaker 4: company compared to a pharmacy. He's like, oh my god,
15:10
Speaker 4: it takes like three weeks to get a document approved
15:14
Speaker 4: just so I can share it.
15:14
Speaker 5: I don't understand why.
15:16
Speaker 4: And I had to explain the concept of MLR to him,
15:19
Speaker 4: of medical legal regulatory review, because if you're going to
15:21
Speaker 4: put something out and people are going to believe you,
15:25
Speaker 4: the fines and penalties that go along with it are
15:28
Speaker 4: significantly more. If you're a pharmacy and you were going
15:32
Speaker 4: no one's going to notice that anymore. Well, guess what
15:34
Speaker 4: you're operating in one of the most profitable systems there is.
15:39
Speaker 4: And yeah, it's very much an area that people care
15:41
Speaker 4: about and you might get sued for that.
15:44
Speaker 5: So compliance is.
15:47
Speaker 4: Very much an issue. I see mistakes. I can't think
15:51
Speaker 4: of an AI document or write up I've seen that
15:56
Speaker 4: has had no mistakes. And this is going back now
16:00
Speaker 4: four or five years. Like you always either has something
16:03
Speaker 4: off a by the tone the information itself, like it's
16:06
Speaker 4: it's like.
16:07
Speaker 6: It it understood the information but not quite And that
16:12
Speaker 6: was my experience with it, Like you got to like
16:15
Speaker 6: you'd get a solid C minus, but I can get
16:18
Speaker 6: you to a C yet.
16:20
Speaker 3: Right well, And I think the irony with you know,
16:24
Speaker 3: independence especially is you're trying to come across as like
16:27
Speaker 3: this personable, yeah, you know in the community, that sort
16:31
Speaker 3: of thing. And then the content that you're putting out
16:34
Speaker 3: on your website social media is that messaging is not
16:37
Speaker 3: matching when you're using AI, so you're just losing people,
16:41
Speaker 3: like you said, just scrolling.
16:43
Speaker 4: Past, I'll give you I've never seen this version, but
16:46
Speaker 4: this is an example of the type of mistakes you'd see.
16:49
Speaker 5: Come to your local.
16:50
Speaker 4: Pharmacy at the corner of eerie infentin and we'll give
16:55
Speaker 4: you blah blah blah. Except there's no ear infent in
16:57
Speaker 4: your neighborhood. I would totally be gassed going. I don't
17:00
Speaker 4: know where Ian Fenton is. Maybe I just don't live here,
17:03
Speaker 4: or maybe I like, it's an area I haven't been to,
17:05
Speaker 4: except AI generated that and anyone who's not looking is
17:09
Speaker 4: going it seems okay, right, But it feels like AI
17:15
Speaker 4: seems to gas like you more than it should.
17:18
Speaker 5: But that's just my take. Yeah.
17:21
Speaker 3: It also just seems like an easy avenue for kind
17:24
Speaker 3: of back to these lawsuits, you know, for lawyers just
17:28
Speaker 3: to start peruising websites for you know, copyrighted photos that
17:33
Speaker 3: people are using that AI was like, use this one,
17:36
Speaker 3: it's okay, or you know, pulling content from websites without sourcing.
17:41
Speaker 3: It just seems like a dangerous road to go down
17:47
Speaker 3: for any business pharmacies, you know, especially I think.
17:52
Speaker 5: Agree with you.
17:53
Speaker 4: I think the the way it works, and most people
17:57
Speaker 4: haven't read the terms of service actually tried to. This
17:59
Speaker 4: is going back probably three years. I haven't re reviewed.
18:02
Speaker 4: I should probably do that at some point, but I
18:05
Speaker 4: tried to look at what each tool gives you, uh,
18:11
Speaker 4: and I'm going to get the order of these mixed up,
18:13
Speaker 4: and who goes with what I might get mixed up,
18:15
Speaker 4: But the general thrust remains the same, which is, I
18:18
Speaker 4: want to say, open Ai says that you own what
18:21
Speaker 4: I own. So whatever if you put a prompt, you
18:26
Speaker 4: own what I own. So this way you can have
18:28
Speaker 4: control of that. Except what they don't tell you is
18:31
Speaker 4: that open AI I got sued because they don't own anything, right,
18:34
Speaker 4: they stole it.
18:35
Speaker 5: Okay.
18:36
Speaker 4: Then I want to say anthropics says you own the
18:40
Speaker 4: right to the prompts. Well, no shit, I own the
18:44
Speaker 4: right to the prompts. I'm the one to put it in.
18:46
Speaker 5: I want the.
18:47
Speaker 4: Everything else that and then there's the third one. I'll
18:54
Speaker 4: and this again going back a few years. But Google Gemini,
18:56
Speaker 4: I think said, uh, it was just silent on it.
18:59
Speaker 4: It didn't say who owned anything. So my point is
19:03
Speaker 4: these companies are being staffed by very very expensive, very
19:09
Speaker 4: very good lawyers.
19:10
Speaker 5: They're not taking the liability. So guess who is you are?
19:14
Speaker 5: So keep that in mind as you continue as well.
19:18
Speaker 3: I'm just going to cut that little snippet and just
19:20
Speaker 3: have it as a bite for when we get stuff
19:23
Speaker 3: from clients or we're like, no, this is why we're
19:29
Speaker 3: saying no, it's yeah. Any other kind of common mistakes
19:37
Speaker 3: that you, you know, when working with pharmacies you see
19:41
Speaker 3: that they're making for us. It's like just you know,
19:45
Speaker 3: not adding the proper disclaimers, trying to make claims that
19:50
Speaker 3: aren't accurate. But I guess anything else that kind of
19:54
Speaker 3: sticks out to you that people should be aware of
19:58
Speaker 3: that they should probably already be aware of it, maybe
20:00
Speaker 3: aren't paying attention to.
20:04
Speaker 4: I can think of several. One is a disclaimer doesn't
20:09
Speaker 4: let you. It's not a get out of jail free card, right, So,
20:13
Speaker 4: if you are a pharmacy that's using disclaimers, you'll see
20:17
Speaker 4: this often. And I've seen that you make this fantastic
20:21
Speaker 4: claim this drug is I'm making this up or maybe
20:24
Speaker 4: I'm not. You might see compounded medications that are they
20:29
Speaker 4: have these fantastic claims along with it. It's completely unapproved
20:33
Speaker 4: and you're and you think you're going to get away
20:37
Speaker 4: with it because why not, except that might come back
20:40
Speaker 4: to bite you and you can just go, oh, this
20:42
Speaker 4: has not been approved by the f Well, no, ship
20:44
Speaker 4: it has. Excuse my line, but no, crap, it's it's
20:47
Speaker 4: not been approved by the FDA. So number one, keep
20:51
Speaker 4: track of those off label may be appropriate in very
20:54
Speaker 4: specific situations, this is not that situation. Talk talk to
20:59
Speaker 4: your lawyer. Find I'm not your lawyer. This is not
21:02
Speaker 4: legal advice, but keep track of what applies. Another one
21:05
Speaker 4: that pops in mind is uh, privacy in the In
21:10
Speaker 4: the context of privacy, there is how are you coming
21:16
Speaker 4: up to the data? For example, are you putting the
21:18
Speaker 4: data into AI? I see that happen everything every so
21:21
Speaker 4: often as well. That's a violation of multiple, multiple laws.
21:26
Speaker 4: Then there is the actual of following can spam laws,
21:30
Speaker 4: tcp A laws if you're texting people following the do
21:35
Speaker 4: not Call list and in the track of that. TCP
21:38
Speaker 4: is probably the most litigated lawsuits in the world right now.
21:41
Speaker 5: So with texting and stuff, yea, with texting.
21:44
Speaker 4: And stuff and people don't know that they're supposed to register,
21:47
Speaker 4: get it all done, and it's hugely problematic. So I
21:51
Speaker 4: think there are loads of areas that pharmacists need to
21:55
Speaker 4: comply with, and everyone seems to operate with the I'm
21:59
Speaker 4: just going to be the I'm going to be the
22:01
Speaker 4: forth Fiesta.
22:02
Speaker 5: Driving on the highway that I know.
22:04
Speaker 4: There's a Mercedes driving on as well, So I hope
22:06
Speaker 4: they catch the Mercedes and not the Ford Fiesta. But
22:10
Speaker 4: you know what, every so often the Mercedes is still
22:12
Speaker 4: far behind, they can still catch the Ford Fiesta as well.
22:16
Speaker 5: Got I hope there's a version called a fort Fiesta. Yeah,
22:19
Speaker 5: yeah there is.
22:20
Speaker 3: Yeah, it's a little car.
22:22
Speaker 5: Yeah yeah. No.
22:25
Speaker 3: Those are all great points, and I mean something so
22:29
Speaker 3: with websites and social media specifically, like a recent development
22:33
Speaker 3: of ADA changes and making sure you know your stuff
22:38
Speaker 3: is compliant, and we're still seeing some of that where
22:43
Speaker 3: you know, pharmacies don't want to pay to add the
22:46
Speaker 3: widget to the website, and kind of going back to
22:49
Speaker 3: what you were saying with GLP wants, it's like, what's
22:51
Speaker 3: your comfort level? You know, this little widget is like
22:54
Speaker 3: fifty bucks a month. If you happen to get sued,
22:57
Speaker 3: it's going to be you know, thousands of dollars you're
23:00
Speaker 3: going to have to potentially pay out. So sometimes I
23:04
Speaker 3: think it's hard for them to just want to take
23:08
Speaker 3: that step either paying for it or you know, making
23:11
Speaker 3: sure everything is on the up and up.
23:13
Speaker 4: I think another area that I think both of us
23:16
Speaker 4: will probably land up advising a lot of these clients
23:18
Speaker 4: about is make sure that your insurance has appropriate coverage
23:21
Speaker 4: for this stuff. Yeah, I find out that your insurance
23:24
Speaker 4: doesn't cover you or that the limits are very, very low,
23:29
Speaker 4: and go talk to your insurance provider and make sure
23:33
Speaker 4: they're covering you properly. And don't let them tell you
23:35
Speaker 4: the cheapest thing in the world, because the cheapest thing
23:38
Speaker 4: doesn't protect you. Look for the one that's right for you.
23:42
Speaker 4: So I have nothing to do with insurance. I'm happy
23:44
Speaker 4: to refer you if you want, but it has nothing
23:47
Speaker 4: to do with me. But I tell this to all
23:49
Speaker 4: my clients, whether it's pharma, pharma, steel companies, medical device companies,
23:53
Speaker 4: or pharmacies. The goal of insurance is always to protect you,
23:56
Speaker 4: and if you don't have the right coverage, you're not
23:59
Speaker 4: being covered and that's problematic.
24:01
Speaker 3: Yeah, excellent point. Well, anything else to share with our
24:05
Speaker 3: listeners before we wrap it up.
24:09
Speaker 4: No, I think we covered a lot of ground. If
24:13
Speaker 4: people like what we're saying, they can come back talk
24:15
Speaker 4: to me, talk to you, and I'm sure they'll get
24:18
Speaker 4: some more information.
24:19
Speaker 5: And if you need to reach me, you can reach me.
24:22
Speaker 4: At Darshan d A R. S h A n At
24:24
Speaker 4: Klokarnilawfirm dot com. That's k U l k a r
24:27
Speaker 4: n I Lawfirm dot com. Or you can reach Nicole
24:31
Speaker 4: and you know she's very very approachable and obviously very
24:34
Speaker 4: very smart, so you should you should reach out to
24:36
Speaker 4: her as well. Well.
24:38
Speaker 3: Thank you for being a guest on the show. Is
24:40
Speaker 3: great to chat with you.
24:41
Speaker 5: Thank you again, Nicole, I appreciate it.
24:44
Speaker 3: And if you need to reach me, you can find
24:45
Speaker 3: me at g r X Marketing dot com or Finch
24:49
Speaker 3: Marketing Solutions dot com. Thanks for joining us for another
24:52
Speaker 3: episode of Marketing Vitals podcast, part of the Pharmacy Podcast Network.
25:01
Speaker 2: The